Leah Rush

Stock Analyst at Brookline Capital

(2.58)

# 2,917

Out of 5,182 analysts

2

Total ratings

100%

Success rate

33.45%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Leah Rush

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	CCCC C4 Therapeutics	Maintains: Buy	$20 → $30	$2.92	+927.40%	1	Feb 23, 2026
	EXEL Exelixis	Initiates: Buy	n/a	$44.89	-	1	Dec 23, 2024

C4 Therapeutics

Feb 23, 2026

Maintains: Buy

Price Target: $20 → $30

Current: $2.92

Upside: +927.40%

Exelixis

Dec 23, 2024

Initiates: Buy

Price Target: n/a

Current: $44.89

Upside: -